Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host

Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology

Volumn 146, Issue 4, 2007, Pages 601-620

  Maya, Juan Diego ^a   Cassels, Bruce K ^a   Iturriaga Vásquez, Patricio ^a   Ferreira, Jorge ^a   Faúndez, Mario ^a   Galanti, Norbel ^a   Ferreira, Arturo ^a   Morello, Antonio ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Benznidazole; Glutathione; Immune system; Macrophages; Natural antichagasic compounds; Nifurtimox; Nitric oxide; Prostaglandins; Review; Trypanosoma cruzi; Trypanothione

Indexed keywords

ALKALOID DERIVATIVE; ALLOPURINOL; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; CYSTEINE; ENZYME; ERGOSTEROL; FREE RADICAL; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE SYNTHASE; ITRACONAZOLE; LIGNAN DERIVATIVE; LIPID; MILTEFOSINE; NIFURTIMOX; NITRIC OXIDE; NITROIMIDAZOLE DERIVATIVE; NITROREDUCTASE; NUCLEIC ACID; PHOSPHOLIPID DERIVATIVE; PROTEIN DERIVATIVE; PURINE DERIVATIVE; SPERMIDINE; STEROL; THIOL; THIOL DERIVATIVE; TRYPANOTHIONE; UNINDEXED DRUG;

ANOREXIA; CELL DAMAGE; CENTRAL NERVOUS SYSTEM DEPRESSION; DERMATITIS; DRUG CONJUGATION; DRUG DETOXIFICATION; DRUG MECHANISM; DRUG RESEARCH; HEADACHE; HOST; HUMAN; MAMMAL; MANIA; NAUSEA; NONHUMAN; PARESTHESIA; POLYNEUROPATHY; RECOMMENDED DRUG DOSE; RESPIRATORY CHAIN; REVIEW; SEIZURE; SIDE EFFECT; STEROL METABOLISM; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VERTIGO; VOMITING;

ANIMALIA; MAMMALIA; TRYPANOSOMA CRUZI; TRYPANOSOMATIDAE;

EID: 33847377170     PISSN: 10956433     EISSN: 15314332     Source Type: Journal    
DOI: 10.1016/j.cbpa.2006.03.004     Document Type: Review

References (209)

1. Abe F., Nagafuji S., Yamauchi T., Okabe H., Maki J., Higo H., Akahane H., Aguilar A., Jimenez-Estrada M., and Reyes-Chilpa R. Trypanocidal constituents in plants: 1. Evaluation of some Mexican plants for their trypanocidal activity and active constituents in Guaco, roots of Aristolochia taliscana. Biol. Pharm. Bull. 25 (2002) 1188-1191
2. Abe F., Yamauchi T., Nagao T., Kinjo J., Okabe H., Higo H., and Akahane H. Ursolic acid as a trypanocidal constituent in rosemary. Biol. Pharm. Bull. 25 (2002) 1485-1487
3. Abe F., Nagafuji S., Okabe H., Higo H., and Akahane H. Trypanocidal constituents in plants: 2. Xanthones from the stem bark of Garcinia subelliptica. Biol. Pharm. Bull. 26 (2003) 1730-1733
4. Abe F., Nagafuji S., Okabe H., Akahane H., Estrada-Muniz E., Huerta-Reyes M., and Reyes-Chilpa R. Trypanocidal constituents in plants: 3. Leaves of Garcinia intermedia and heartwood of Calophyllum brasiliense. Biol. Pharm. Bull. 27 (2004) 141-143
5. Abegaz B.M., Bezabih M., Msuta T., Brun R., Menche D., Muhlbacher J., and Bringmann G. Gaboroquinones A and B and 4′-O-demethylknipholone-4′-O-beta-d-glucopyranoside, phenylanthraquinones from the roots of Bulbine frutescens. J. Nat. Prod. 65 (2002) 1117-1121
6. Aldunate J., and Morello A. Free radicals in the mode of action of parasitic drugs. In: Aruoma O.I. (Ed). Free Radicals in Tropical Diseases (1993), Harwood Academic Publishers, Switzerland 137-165
7. Aldunate J., Ferreira J., Letelier M.E., Repetto Y., and Morello A. t-Butyl-4-hydroxyanisole, a novel respiratory chain inhibitor. Effects on Trypanosoma cruzi epimastigotes. FEBS Lett. 195 (1986) 295-297
8. Alvarez M.N., Trujillo M., and Radi R. Peroxynitrite formation from biochemical and cellular fluxes of nitric oxide and superoxide. Methods Enzymol. 359 (2002) 353-366
9. Anderson M.E. Glutathione: an overview of biosynthesis and modulation. Chem.-Biol. Interact. 111-112 (1998) 1-14
10. Anderson C.P., and Reynolds C.P. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy. Bone Marrow Transplant. 30 (2002) 135-140
11. Anderson C.P., Seeger R.C., Satake N., Monforte-Muñoz H.L., Keshelava N., Bailey H.H., and Reynolds C.P. Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line. J. Pediatr. Hematol./Oncol. 23 (2001) 500-505
12. Andrade L.O., and Andrews N.W. Lysosomal fusion is essential for the retention of Trypanosoma cruzi inside host cells. J. Exp. Med. 200 (2004) 1135-1143
13. Apt W. Tratamiento de la Enfermedad de Chagas. Parasitol. Día 23 (1999) 100-112
14. Apt W., Aguilera X., Arribada A., Perez C., Miranda C., Sanchez G., Zulantay I., Cortes P., Rodriguez J., and Juri D. Treatment of chronic Chagas' disease with itraconazole and allopurinol. Am. J. Trop. Med. Hyg. 59 (1998) 133-138
15. Apt W., Arribada A., Zulantay I., Sanchez G., Vargas S.L., and Rodriguez J. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up. Ann. Trop. Med. Parasitol. 97 (2003) 23-29
16. Araya J.E., Neira I., da Silva S., Mortara R.A., Manque P., Cordero E., Sagua H., Loyola A., Bórquez J., Morales G., and González J. Diterpenoids from Azorella compacta (Umbelliferae) active on Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 98 (2003) 413-418
17. Ariyanayagam M.R., and Fairlamb A.H. Ovothiol and trypanothione as antioxidants in trypanosomatids. Mol. Biochem. Parasitol. 115 (2001) 189-198
18. Ariyanayagam M.R., Oza S.L., Mehlert A., and Fairlamb A.H. Bis(glutathionyl)spermine and other novel trypanothione analogues in Trypanosoma cruzi. J. Biol. Chem. 278 (2003) 27612-27619
19. Arrick B.A., Griffith O.W., and Cerami A. Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis. J. Exp. Med. 153 (1981) 720-725
20. Arzel E., Rocca P., Grellier P., Labaeid M., Frappier F., Gueritte F., Gaspard C., Marsais F., Godard A., and Queguiner G. New synthesis of benzo-delta-carbolines, cryptolepines, and their salts: in vitro cytotoxic, antiplasmodial, and antitrypanosomal activities of delta-carbolines, benzo-delta-carbolines, and cryptolepines. J. Med. Chem. 44 (2001) 949-960
21. Asres K., Bucar F., Knauder E., Yardley V., Kendrick H., and Croft S.L. In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle. Phytother. Res. 15 (2001) 613-617
22. Aufderheide A.C., Salo W., Madden M., Streitz J., Buikstra J., Guhl F., Arriaza B., Renier C., Wittmers Jr. L.E., Fornaciari G., and Allison M. A 9000-year record of Chagas' disease. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2034-2039
23. Augustyns K., Amssoms K., Yamani A., Rajan P.K., and Haemers A. Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents. Curr. Pharm. Des. 7 (2001) 1117-1141
24. Avila J.L., and Avila A. Trypanosoma cruzi: allopurinol in the treatment of mice with experimental acute Chagas disease. Exp. Parasitol. 51 (1981) 204-208
25. Avila J.L., Avila A., and Monzón H. Differences in allopurinol and 4-aminopyrazolo(3,4-d) pyrimidine metabolism in drug-sensitive and insensitive strains of Trypanosoma cruzi. Mol. Biochem. Parasitol. 11 (1984) 51-60
26. Bailey H.H., Mulcahy R.T., Tutsch K.D., Arzoomanian R.Z., Alberti D., Tombes M.B., Wilding G., Pomplun M., and Spriggs D.R. Phase I clinical trial of intravenous l-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J. Clin. Oncol. 12 (1994) 194-205
27. Bailey H.H., Ripple G., Tutsch K.D., Arzoomanian R.Z., Alberti D., Feierabend C., Mahvi D., Schink J., Pomplun M., Mulcahy R.T., and Wilding G. Phase I study of continuous-infusion l-S,R-buthionine sulfoximine with intravenous melphalan. J. Natl. Cancer Inst. 89 (1997) 1789-1796
28. Bennett J.E. Antimicrobial agents: antifungal agents. In: Goodman L.S., Gilman A.G., Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics (2001), McGraw-Hill, Medical Publishing Division, New York 1295-1312
29. Berens R.L., Marr J.J., LaFon S.W., and Nelson D.J. Purine metabolism in Trypanosoma cruzi. Mol. Biochem. Parasitol. 3 (1981) 187-196
30. Berger I., Passreiter C.M., Cáceres A., and Kubelka W. Antiprotozoal activity of Neurolaena lobata. Phytother. Res. 15 (2001) 327-330
31. Brand G.D., Leite J.R., Silva L.P., Albuquerque S., Prates M.V., Azevedo R.B., Carregaro V., Silva J.S., Sa V.C., Brandão R.A., and Bloch Jr. C. Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells. J. Biol. Chem. 277 (2002) 49332-49340
32. Brandonisio O., Panaro M.A., Sisto M., Acquafredda A., Fumarola L., Leogrande D., and Mitolo V. Nitric oxide production by Leishmania-infected macrophages and modulation by cytokines and prostaglandins. Parassitologia 43 Suppl 1 (2001) 1-6
33. Branen A.L. Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene. J. Am. Oil Chem. Soc. 52 (1975) 59-63
34. Bravo B.J., Sauvain M., Giménez T.A., Balanza E., Serani L., Laprevôte O., Massiot G., and Lavaud C. Trypanocidal withanolides and withanolide glycosides from Dunalia brachyacantha. J. Nat. Prod. 64 (2001) 720-725
35. Bringmann G., Hamm A., Günther C., Michel M., Brun R., and Mudogo V. Ancistroealaines A and B, two new bioactive naphthylisoquinolines, and related naphthoic acids from Ancistrocladus ealaensis. J. Nat. Prod. 63 (2000) 1465-1470
36. Bringmann G., Messer K., Brun R., and Mudogo V. Ancistrocongolines A-D, new naphthylisoquinoline alkaloids from Ancistrocladus congolensis. J. Nat. Prod. 65 (2002) 1096-1101
37. Bringmann G., Messer K., Wolf K., Muhlbacher J., Grune M., Brun R., and Louis A.M. Dioncophylline E from Dioncophyllum thollonii, the first 7,3′-coupled Dioncophyllaceous naphthylisoquinoline alkaloid. Phytochemistry 60 (2002) 389-397
38. Bringmann G., Dreyer M., Faber J.H., Dalsgaard P.W., Staerk D., Jaroszewski J.W., Ndangalasi H., Mbago F., Brun R., Reichert M., Maksimenka K., and Christensen S.B. Ancistrotanzanine A, the first 5,3′-coupled naphthylisoquinoline alkaloid, and two further, 5,8′-linked related compounds from the newly described species Ancistrocladus tanzaniensis. J. Nat. Prod. 66 (2003) 1159-1165
39. Bringmann G., Messer K., Schwobel B., Brun R., and Ake A.L. Habropetaline A, an antimalarial naphthylisoquinoline alkaloid from Triphyophyllum peltatum. Phytochemistry 62 (2003) 345-349
40. Bringmann G., Saeb W., Ruckert M., Mies J., Michel M., Mudogo V., and Brun R. Ancistrolikokine D, a 5,8′-coupled naphthylisoquinoline alkaloid, and related natural products from Ancistrocladus likoko. Phytochemistry 62 (2003) 631-636
41. Bringmann G., Dreyer M., Faber J.H., Dalsgaard P.W., Staerk D., Jaroszewski J.W., Ndangalasi H., Mbago F., Brun R., and Christensen S.B. Ancistrotanzanine C and related 5,1′- and 7,3′-coupled naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis. J. Nat. Prod. 67 (2004) 743-748
42. Bringmann G., Dreyer M., Rischer H., Wolf K., Hadi H.A., Brun R., Meimberg H., and Heubl G. Ancistrobenomine a, the first naphthylisoquinoline oxygenated at Me-3, and related 5,1′-coupled alkaloids, from the "new" plant species Ancistrocladus benomensis. J. Nat. Prod. 67 (2004) 2058-2062
43. Bringmann G., Dreyer M., Kopff H., Rischer H., Wohlfarth M., Hadi H.A., Brun R., Meimberg H., and Heubl G. ent-Dioncophylleine A and related dehydrogenated naphthylisoquinoline alkaloids, the first Asian Dioncophyllaceae-type alkaloids, from the "new" plant species Ancistrocladus benomensis. J. Nat. Prod. 68 (2005) 686-690
44. Brodskyn C., Patricio J., Oliveira R., Lobo L., Arnholdt A., Mendonça-Previato L., Barral A., and Barral-Netto M. Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses. Infect. Immun. 70 (2002) 3736-3743
45. Bua J., Ruiz A.M., Potenza M., and Fichera L.E. In vitro anti-parasitic activity of Cyclosporin A analogs on Trypanosoma cruzi. Bioorg. Med. Chem. Lett. 14 (2004) 4633-4637
46. Burleigh B.A., and Woolsey A.M. Cell signalling and Trypanosoma cruzi invasion. Cell. Microbiol. 4 (2002) 701-711
47. Cabral M.M., Azambuja P., Gottlieb O.R., Kleffmann T., García E.S., and Schaub G.A. Burchellin: effects on Triatoma infestans and on Trypanosoma cruzi within this vector. Parasitol. Res. 87 (2001) 730-735
48. Caler E.V., Morty R.E., Burleigh B.A., and Andrews N.W. Dual role of signaling pathways leading to Ca(2+) and cyclic AMP elevation in host cell invasion by Trypanosoma cruzi. Infect. Immun. 68 (2000) 6602-6610
49. Calvert P., Yao K.S., Hamilton T.C., and O'Dwyer P.J. Clinical studies of reversal of drug resistance based on glutathione. Chem. Biol. Interact. 111-112 (1998) 213-224
50. Campos M.A., Almeida I.C., Takeuchi O., Akira S., Valente E.P., Procopio D.O., Travassos L.R., Smith J.A., Golenbock D.T., and Gazzinelli R.T. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167 (2001) 416-423
51. Cardona Zuleta L.M., Cavalheiro A.J., Siqueira Silva D.H., Furlan M., Marx Young M.C., Albuquerque S., Castro-Gamboa I., and da Silva Bolzani V. Seco-iridoids from Calycophyllum spruceanum (Rubiaceae). Phytochemistry 64 (2003) 549-553
52. Cazzulo J.J. Proteinases of Trypanosoma cruzi: potential targets for the chemotherapy of Chagas desease. Curr. Top. Med. Chem. 2 (2002) 1261-1271
53. Cazzulo J.J., Stoka V., and Turk V. The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease. Curr. Pharm. Des. 7 (2001) 1143-1156
54. Chagas C. Nova tripanosomiase humana. Estudios sobre a morfología e o ciclo evolutivo do Schizotrypanum cruzi n. gen, n. sp., agente etiológico do nova entidae mórbida do homen. Mem. Inst. Oswaldo Cruz. Mem. Inst. Oswaldo Cruz 1 (1909) 159-218
55. Chowdhury S.F., Guerrero R.H., Brun R., Ruiz-Pérez L.M., Pacanowska D.G., and Gilbert I.H. Synthesis and testing of 5-benzyl-2,4-diaminopyrimidines as potential inhibitors of leishmanial and trypanosomal dihydrofolate reductase. J. Enzyme Inhib. Med. Chem. 17 (2002) 293-302
56. Cuéllar M.A., Salas C., Cortés M.J., Morello A., Maya J.D., and Preite M.D. Synthesis and in vitro trypanocide activity of several polycyclic drimane-quinone derivatives. Bioorg. Med. Chem. 11 (2003) 2489-2497
57. Cummings K.L., and Tarleton R.L. Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect. Immun. 72 (2004) 4081-4089
58. Darsaud A., Chevrier C., Bourdon L., Dumas M., Buguet A., and Bouteille B. Megazol combined with suramin improves a new diagnosis index of the early meningo-encephalitic phase of experimental African trypanosomiasis. Trop. Med. Int. Health 9 (2004) 83-91
59. da Silva Filho A.A., Pires Bueno P.C., Gregorio L.E., Andrade e Silva M.L., Albuquerque S., and Bastos J.K. In-vitro trypanocidal activity evaluation of crude extract and isolated compounds from Baccharis dracunculifolia D.C. (Asteraceae). J. Pharm. Pharmacol. 56 (2004) 1195-1199
60. de Barros-Mazon S., Guariento M.E., da Silva C.A., Coffman R.L., and Abrahamsohn I.A. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease. Clin. Immunol. 111 (2004) 137-145
61. De Carvalho E.A., Andrade P.P., Silva N.H., Pereira E.C., and Figueiredo R.C. Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: an ultrastructural study. Micron 36 (2005) 155-161
62. de Marchi A.A., Castilho M.S., Nascimento P.G., Archanjo F.C., del Ponte G., Oliva G., and Pupo M.T. New 3-piperonylcoumarins as inhibitors of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) from Trypanosoma cruzi. Bioorg. Med. Chem. 12 (2004) 4823-4833
63. de Oliveira C., Santana L.A., Carmona A.K., Cezari M.H., Sampaio M.U., Sampaio C.A., and Oliva M.L. Structure of cruzipain/cruzain inhibitors isolated from Bauhinia bauhinioides seeds. Biol. Chem. 382 (2001) 847-852
64. De Souza E.M., Araujo-Jorge T.C., Bailly C., Lansiaux A., Batista M.M., Oliveira G.M., and Soeiro M.N. Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models. Cell Tissue Res. 314 (2003) 223-235
65. de Souza V., da Silva R., Pereira A.C., Royo V.A., Saraiva J., Montanheiro M., de Souza G.H., da Silva Filho A.A., Grando M.D., Donate P.M., Bastos J.K., Albuquerque S., and Silva M.L. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi. Bioorg. Med. Chem. Lett. 15 (2005) 303-307
66. del Olmo E., Armas M.G., López-Pérez J.L., Ruiz G., Vargas F., Giménez A., Deharo E., and San Feliciano A. Anti-Trypanosoma activity of some natural stilbenoids and synthetic related heterocyclic compounds. Bioorg. Med. Chem. Lett. 11 (2001) 2755-2757
67. Díaz de Toranzo E.G., Castro J.A., Franke de Cazzulo B.M., and Cazzulo J.J. Interaction of benznidazole reactive metabolites with nuclear and kinetoplastic DNA, proteins and lipids from Trypanosoma cruzi. Experientia 44 (1988) 880-881
68. Docampo R., and Stoppani A.O. Generation of superoxide anion and hydrogen peroxide induced by nifurtimox in Trypanosoma cruzi. Arch. Biochem. Biophys. 197 (1979) 317-321
69. Docampo R., and Stoppani A.O. Mechanism of the trypanocidal action of nifurtimox and other nitro-derivatives on Trypanosoma cruzi. Medicina (B Aires) 40 Suppl. 1 (1980) 10-16
70. Docampo R., and Moreno S.N. Free radical metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi. Rev. Infect. Dis. 6 (1984) 223-238
71. Docampo R., Moreno S.N., Stoppani A.O., León W., Cruz F.S., Villalta F., and Muñiz R.F. Mechanism of nifurtimox toxicity in different forms of Trypanosoma cruzi. Biochem. Pharmacol. 30 (1981) 1947-1951
72. Dormeyer M., Reckenfelderbaumer N., Ludemann H., and Krauth-Siegel R.L. Trypanothione-dependent synthesis of deoxyribonucleotides by Trypanosoma brucei ribonucleotide reductase. J. Biol. Chem. 276 (2001) 10602-10606
73. DosReis G.A., Pecanha L.M., Bellio M., Previato J.O., and Mendonça-Previato L. Glycoinositol phospholipids from Trypanosoma cruzi transmit signals to the cells of the host immune system through both ceramide and glycan chains. Microbes Infect. 4 (2002) 1007-1013
74. Eakin A.E., Guerra A., Focia P.J., Torres-Martínez J., and Craig III S.P. Hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi as a target for structure-based inhibitor design: crystallization and inhibition studies with purine analogs. Antimicrob. Agents Chemother. 41 (1997) 1686-1692
75. Elion G.B., and Nelson D.J. Ribonucleotides of allopurinol and oxipurinol in rat tissues and their significance in purine metabolism. Adv. Exp. Med. Biol. 41 (1974) 639-652
76. Elion G.B., Yu T.F., Gutman A.B., and Hitchings G.H. Renal clearance of oxipurinol, the chief metabolite of allopurinol. Am. J. Med. 45 (1968) 69-77
77. Enanga B., Ariyanayagam M.R., Stewart M.L., and Barrett M.P. Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage. Antimicrob. Agents Chemother. 47 (2003) 3368-3370
78. Espindola L.S., Vasconcelos Jr. J., de Mesquita M.L., Marquie P., de Paula J.E., Mambu L., and Santana J.M. Trypanocidal activity of a new diterpene from Casearia sylvestris var. lingua. Planta Med. 70 (2004) 1093-1095
79. Fabrino D.L., Leon L.L., Parreira G.G., Genestra M., Almeida P.E., and Melo R.C. Peripheral blood monocytes show morphological pattern of activation and decreased nitric oxide production during acute Chagas' disease in rats. Nitric Oxide 11 (2004) 166-174
80. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 (1998) 890-898
81. Fairlamb A.H., and Cerami A. Metabolism and functions of trypanothione in the Kinetoplastida. Annu. Rev. Microbiol. 46 (1992) 695-729
82. Faúndez M., Pino L., Letelier P., Ortiz C., López R., Seguel C., Ferreira J., Pavani M., Morello A., and Maya J.D. Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi. Antimicrob. Agents Chemother. 49 (2005) 126-130
83. Feresin G.E., Tapia A., Sortino M., Zacchino S., de Arias A.R., Inchausti A., Yaluff G., Rodríguez J., Theoduloz C., and Schmeda-Hirschmann G. Bioactive alkyl phenols and embelin from Oxalis erythrorhiza. J. Ethnopharmacol. 88 (2003) 241-247
84. Fernandes A.P., and Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid. Redox Signal. 6 (2004) 63-74
85. Ferreira J., Coloma L., Fones E., Letelier M.E., Repetto Y., Morello A., and Aldunate J. Effects of t-butyl-4-hydroxyanisole and other phenolic antioxidants on tumoral cells and Trypanosoma parasites. FEBS Lett. 234 (1988) 485-488
86. Filardi L.S., and Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 81 (1987) 755-759
87. Fong C.Y., Pang L., Holland E., and Knox A.J. TGF-beta1 stimulates IL-8 release, COX-2 expression, and PGE(2) release in human airway smooth muscle cells. Am. J. Physiol., Lung Cell. Mol. Physiol. 279 (2000) L201-L207
88. Freire-de-Lima C.G., Nascimento D.O., Soares M.B., Bozza P.T., Castro-Faria-Neto H.C., de Mello F.G., DosReis G.A., and Lopes M.F. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403 (2000) 199-203
89. Freymann D.M., Wenck M.A., Engel J.C., Feng J., Focia P.J., Eakin A.E., and Craig S.P. Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi. Chem. Biol. 7 (2000) 957-968
90. Gertsch J., Tobler R.T., Brun R., Sticher O., and Heilmann J. Antifungal, antiprotozoal, cytotoxic and piscicidal properties of Justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum. Planta Med. 69 (2003) 420-424
91. Goñi O., Alcaide P., and Fresno M. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+)immature myeloid suppressor cells. Int. Immunol. 14 (2002) 1125-1134
92. Grael C.F., Albuquerque S., and Lopes J.L. Chemical constituents of Lychnophora pohlii and trypanocidal activity of crude plant extracts and of isolated compounds. Fitoterapia 76 (2005) 73-82
93. Griffith O.W., and Mulcahy R.T. The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Advan. Enzymol. Relat. Areas Mol. Biol. 73 (1999) 209-267 (xii)
94. Gutteridge W.E., and Davies M.J. Enzymes of purine salvage in Trypanosoma cruzi. FEBS Lett. 127 (1981) 211-214
95. Gutteridge J.M., and Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann. N.Y. Acad. Sci. 899 (2000) 136-147
96. Haddad J.J. The involvement of l-gamma-glutamyl-l-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production. Biochem. Pharmacol. 63 (2002) 305-320
97. Hammond D.J., Gutteridge W.E., and Opperdoes F.R. A novel location for two enzymes of de novo pyrimidine biosynthesis in trypanosomes and Leishmania. FEBS Lett. 128 (1981) 27-29
98. Hayes J.D., and McLellan L.I. Glutathione and glutathione-dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radic. Res. 31 (1999) 273-300
99. Heilmann J., Brun R., Mayr S., Rali T., and Sticher O. Minor cytotoxic and antibacterial compounds from the rhizomes of Amomum aculeatum. Phytochemistry 57 (2001) 1281-1285
100. Hiratake J., Irie T., Tokutake N., and Oda J. Recognition of a cysteine substrate by E. coli gamma-glutamylcysteine synthetase probed by sulfoximine-based transition-state analogue inhibitors. Biosci. Biotechnol. Biochem. 66 (2002) 1500-1514
101. Hoet S., Stevigny C., Block S., Opperdoes F., Colson P., Baldeyrou B., Lansiaux A., Bailly C., and Quetin-Leclercq J. Alkaloids from Cassytha filiformis and related aporphines: antitrypanosomal activity, cytotoxicity, and interaction with DNA and topoisomerases. Planta Med. 70 (2004) 407-413
102. Huynh T.T., Huynh V.T., Harmon M.A., and Phillips M.A. Gene knockdown of gamma-glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme. J. Biol. Chem. 278 (2003) 39794-39800
103. Jonckers T.H., van Miert S., Cimanga K., Bailly C., Colson P., De Pauw-Gillet M.C., van den Heuvel H., Claeys M., Lemiere F., Esmans E.L., Rozenski J., Quirijnen L., Maes L., Dommisse R., Lemiere G.L., Vlietinck A., and Pieters L. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives. J. Med. Chem. 45 (2002) 3497-3508
104. Jones C.M., Lawrence A., Wardman P., and Burkitt M.J. Kinetics of superoxide scavenging by glutathione: an evaluation of its role in the removal of mitochondrial superoxide. Biochem. Soc. Trans. 31 (2003) 1337-1339
105. Jones S.P., Hoffmeyer M.R., Sharp B.R., Ho Y.S., and Lefer D.J. Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion. Am. J. Physiol, Heart Circ. Physiol. 284 (2003) H277-H282
106. Kapoor P., Sachdev M., and Madhubala R. Inhibition of glutathione synthesis as a chemotherapeutic strategy for leishmaniasis. Trop. Med. Int. Health 5 (2000) 438-442
107. Kelly B.S., Antholine W.E., and Griffith O.W. Escherichia coli gamma-glutamylcysteine synthetase. Two active site metal ions affect substrate and inhibitor binding. J. Biol. Chem. 277 (2002) 50-58
108. Khabnadideh S., Pez D., Musso A., Brun R., Pérez L.M., González-Pacanowska D., and Gilbert I.H. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase. Bioorg. Med. Chem. 13 (2005) 2637-2649
109. Kierszenbaum F., Fresno M., and Sztein M.B. The Trypanosoma cruzi membrane glycoprotein AGC10 inhibits human lymphocyte activation by a mechanism preceding translation of both, interleukin-2 and its high-affinity receptor subunits. Mol. Biochem. Parasitol. 125 (2002) 91-101
110. Kim J.G., and Hahn Y.S. IFN-gamma inhibits the suppressive effects of PGE2 on the production of tumor necrosis factor-alpha by mouse macrophages. Immunol. Invest. 29 (2000) 257-269
111. Kirchhoff L.V. American trypanosomiasis (Chagas' disease). In: Rakel R.E. (Ed). Conn's Current Therapy (2000), W. B. Saunders, New York 101-102
112. Kiuchi F., Itano Y., Uchiyama N., Honda G., Tsubouchi A., Nakajima-Shimada J., and Aoki T. Monoterpene hydroperoxides with trypanocidal activity from Chenopodium ambrosioides. J. Nat. Prod. 65 (2002) 509-512
113. Kiuchi F., Matsuo K., Ito M., Qui T.K., and Honda G. New norditerpenoids with trypanocidal activity from Vitex trifolia. Chem. Pharm. Bull. (Tokyo) 52 (2004) 1492-1494
114. Kiuchi F., Matsuo K., Ito M., Qui T.K., and Honda G. New sesquiterpene hydroperoxides with trypanocidal activity from Pogostemon cablin. Chem. Pharm. Bull. (Tokyo) 52 (2004) 1495-1496
115. Krauth-Siegel R.L., and Ludemann H. Reduction of dehydroascorbate by trypanothione. Mol. Biochem. Parasitol. 80 (1996) 203-208
116. Krauth-Siegel R.L., Meiering S.K., and Schmidt H. The parasite-specific trypanothione metabolism of Trypanosoma and Leishmania. Biol. Chem. 384 (2003) 539-549
117. Kuhn H., and Borchert A. Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes. Free Radic. Biol. Med. 33 (2002) 154-172
118. Labraña J., Machocho A.K., Kricsfalusy V., Brun R., Codina C., Viladomat F., and Bastida J. Alkaloids from Narcissus angustifolius subsp. transcarpathicus (Amaryllidaceae). Phytochemistry 60 (2002) 847-852
119. Ladame S., Castilho M.S., Silva C.H., Denier C., Hannaert V., Perie J., Oliva G., and Willson M. Crystal structure of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase complexed with an analogue of 1,3-bisphospho-d-glyceric acid. Eur. J. Biochem. 270 (2003) 4574-4586
120. Ladame S., Faure R., Denier C., Lakhdar-Ghazal F., and Willson M. Selective inhibition of Trypanosoma cruzi GAPDH by "bi-substrate" analogues. Org. Biomol. Chem. 3 (2005) 2070-2072
121. Leite J.R., Silva L.P., Rodrigues M.I., Prates M.V., Brand G.D., Lacava B.M., Azevedo R.B., Bocca A.L., Albuquerque S., and Bloch Jr. C. Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus. Peptides 26 (2005) 565-573
122. Letelier M.E., Rodríguez E., Wallace A., Lorca M., Repetto Y., Morello A., and Aldunate J. Trypanosoma cruzi: a possible control of transfusion-induced Chagas' disease by phenolic antioxidants. Exp. Parasitol. 71 (1990) 357-363
123. Lopes M.F., and DosReis G.A. Experimental Chagas disease: phagocytosis of apoptotic lymphocytes deactivates macrophages and fuels parasite growth. Apoptosis 5 (2000) 221-224
124. Machado C.A., and Ayala F.J. Sequence variation in the dihydrofolate reductase-thymidylate synthase (DHFR-TS) and trypanothione reductase (TR) genes of Trypanosoma cruzi. Mol. Biochem. Parasitol. 121 (2002) 33-47
125. Machocho A.K., Bastida J., Codina C., Viladomat F., Brun R., and Chhabra S.C. Augustamine type alkaloids from Crinum kirkii. Phytochemistry 65 (2004) 3143-3149
126. Magez S., Stijlemans B., Radwanska M., Pays E., Ferguson M.A., and De Baetselier P. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J. Immunol. 160 (1998) 1949-1956
127. Marr J.J., Berens R.L., and Nelson D.J. Antitrypanosomal effect of allopurinol: conversion in vivo to aminopyrazolopyrimidine nucleotides by Trypanosoma cruzi. Science 201 (1978) 1018-1020
128. Martins R.C., Lago J.H., Albuquerque S., and Kato M.J. Trypanocidal tetrahydrofuran lignans from inflorescences of Piper solmsianum. Phytochemistry 64 (2003) 667-670
129. 2 inhibition of nitroreductase. Biochem. Biophys. Res. Commun. 67 (1975) 1267-1274
130. Maya J.D., Repetto Y., Agosin M., Ojeda J.M., Téllez R., Gaule C., and Morello A. Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi. Mol. Biochem. Parasitol. 86 (1997) 101-106
131. Maya J.D., Morello A., Repetto Y., Téllez R., Rodríguez A., Zelada U., Puebla P., Caballero E., Medarde M., Núñez-Vergara L.J., Squella J.A., Bonta M., Bollo S., and San Feliciano A. Effects of 3-chloro-phenyl-1,4-dihydropyridine derivatives on Trypanosoma cruzi epimastigotes. Comp. Biochem. Physiol., C. Toxicol. Pharmacol. 125 (2000) 103-109
132. Maya J.D., Morello A., Repetto Y., Rodríguez A., Puebla P., Caballero E., Medarde M., Núñez-Vergara L.J., Squella J.A., Ortiz M.E., Fuentealba J., and San Feliciano A. Trypanosoma cruzi: inhibition of parasite growth and respiration by oxazolo(thiazolo)pyridine derivatives and its relationship to redox potential and lipophilicity. Exp. Parasitol. 99 (2001) 1-6
133. Maya J.D., Bollo S., Núñez-Vergara L.J., Squella J.A., Repetto Y., Morello A., Perie J., and Chauvière G. Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives. Biochem. Pharmacol. 65 (2003) 999-1006
134. Maya J.D., Rodríguez A., Pino L., Pabon A., Ferreira J., Pavani M., Repetto Y., and Morello A. Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi. Biol. Res. 37 (2004) 61-69
135. Mazur L. Radioprotective effects of the thiols GSH and WR-2721 against X-ray-induction of micronuclei in erythroblasts. Mutat. Res. 468 (2000) 27-33
136. Melo R.C., Fabrino D.L., D'Avila H., Teixeira H.C., and Ferreira A.P. Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell Biol. Int. 27 (2003) 853-861
137. Mendoza D.T., Ureña Gonzalez L.D., Ortega-Barría E., Capson T.L., and Ríos L.C. Five new cassane diterpenes from Myrospermum frutescens with activity against Trypanosoma cruzi. J. Nat. Prod. 66 (2003) 928-932
138. Michailowsky V., Silva N.M., Rocha C.D., Vieira L.Q., Lannes-Vieira J., and Gazzinelli R.T. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am. J. Pathol. 159 (2001) 1723-1733
139. Molina J., Martins-Filho O., Brener Z., Romanha A.J., Loebenberg D., and Urbina J.A. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob. Agents Chemother. 44 (2000) 150-155
140. Montalvetti A., Bailey B.N., Martin M.B., Severin G.W., Oldfield E., and Docampo R. Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase. J. Biol. Chem. 276 (2001) 33930-33937
141. Montalvetti A., Rohloff P., and Docampo R. A functional aquaporin co-localizes with the vacuolar proton pyrophosphatase to acidocalcisomes and the contractile vacuole complex of Trypanosoma cruzi. J. Biol. Chem. 279 (2004) 38673-38682
142. Morello A. The biochemistry of the mode of action of drugs and the detoxication mechanisms in Trypanosoma cruzi. Comp. Biochem. Physiol. C 90 (1988) 1-12
143. Morello A., Lipchenca I., Cassels B.K., Speisky H., Aldunate J., and Repetto Y. Trypanocidal effect of boldine and related alkaloids upon several strains of Trypanosoma cruzi. Comp. Biochem. Physiol., Pharmacol. Toxicol. Endocrinol. 107 (1994) 367-371
144. Moreno S.N., Docampo R., Mason R.P., León W., and Stoppani A.O. Different behaviors of benznidazole as free radical generator with mammalian and Trypanosoma cruzi microsomal preparations. Arch. Biochem. Biophys. 218 (1982) 585-591
145. Nagafuji S., Okabe H., Akahane H., and Abe F. Trypanocidal constituents in plants: 4. Withanolides from the aerial parts of Physalis angulata. Biol. Pharm. Bull. 27 (2004) 193-197
146. Nakajima-Shimada J., Hirota Y., and Aoki T. Inhibition of Trypanosoma cruzi growth in mammalian cells by purine and pyrimidine analogs. Antimicrob. Agents Chemother. 40 (1996) 2455-2458
147. Nakayama H., Ferreira M.E., Rojas de Arias A., Vera de Bilbao N., Torres S., Schinini A., and Fournet A. Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-n-propylquinoline. Phytother. Res. 15 (2001) 630-632
148. Nelson D.J., Bugge C.J., Krasny H.C., and Elion G.B. Formation of nucleotides of (6-14C)allopurinol and (6-14C)oxipurinol in rat tissues and effects on uridine nucleotide pools. Biochem. Pharmacol. 22 (1973) 2003-2022
149. Nelson D.J., LaFon S.W., Jones T.E., Spector T., Berens R.L., and Marr J.J. The metabolism of formycin B in Leishmania donovani. Biochem. Biophys. Res. Commun. 108 (1982) 349-354
150. Nesslany F., Brugier S., Mouries M.A., Le C.F., and Marzin D. In vitro and in vivo chromosomal aberrations induced by megazol. Mutat. Res. 560 (2004) 147-158
151. O'Dwyer P.J., Hamilton T.C., LaCreta F.P., Gallo J.M., Kilpatrick D., Halbherr T., Brennan J., Bookman M.A., Hoffman J., Young R.C., Comis R.L., and Ozols R.F. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J. Clin. Oncol. 14 (1996) 249-256
152. Opperdoes F.R. Biochemical peculiarities of trypanosomes, African and South American. Br. Med. Bull. 41 (1985) 130-136
153. Oza S.L., Tetaud E., Ariyanayagam M.R., Warnon S.S., and Fairlamb A.H. A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi. J. Biol. Chem. 277 (2002) 35853-35861
154. Padwa A., Boonsombat J., Rashatasakhon P., and Willis J. Efficient construction of the oxatricyclo[6.3.1.0(0,0)]dodecane core of komaroviquinone using a cyclization/cycloaddition cascade of a rhodium carbenoid intermediate. Org. Lett. 7 (2005) 3725-3727
155. Pastore A., Federici G., Bertini E., and Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta 333 (2003) 19-39
156. Paulino M., Iribarne F., Dubin M., Aguilera-Morales S., Tapia O., and Stoppani A.O. The chemotherapy of Chagas' disease: an overview. Mini Rev. Med. Chem. 5 (2005) 499-519
157. Paveto C., Guida M.C., Esteva M.I., Martino V., Coussio J., Flawia M.M., and Torres H.N. Anti-Trypanosoma cruzi activity of green tea (Camellia sinensis) catechins. Antimicrob. Agents Chemother. 48 (2004) 69-74
158. Peluffo G., Piacenza L., Irigoin F., Alvarez M.N., and Radi R. L-arginine metabolism during interaction of Trypanosoma cruzi with host cells. Trends Parasitol. 20 (2004) 363-369
159. Pez D., Leal I., Zuccotto F., Boussard C., Brun R., Croft S.L., Yardley V., Ruiz Perez L.M., González P.D., and Gilbert I.H. 2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase. Bioorg. Med. Chem. 11 (2003) 4693-4711
160. Pinge-Filho P., Tadokoro C.E., and Abrahamsohn I.A. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell. Immunol. 193 (1999) 90-98
161. Plum J., Huang C., Grabensee B., Schror K., and Meyer-Kirchrath J. Prostacyclin enhances the expression of LPS/INF-gamma-induced nitric oxide synthase in human monocytes. Nephron 91 (2002) 391-398
162. Pozas R., Carballo J., Castro C., and Rubio J. Synthesis and in vitro antitrypanosomal activity of novel Nifurtimox analogues. Bioorg. Med. Chem. Lett. 15 (2005) 1417-1421
163. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet, Infect. Dis. 1 (2001) 92-100
164. Previato J.O., Wait R., Jones C., DosReis G.A., Todeschini A.R., Heise N., and Previato L.M. Glycoinositolphospholipid from Trypanosoma cruzi: structure, biosynthesis and immunobiology. Adv. Parasitol. 56 (2004) 1-41
165. Ramírez I., Carabot A., Meléndez P., Carmona J., Jiménez M., Patel A.V., Crabb T.A., Blunden G., Cary P.D., Croft S.L., and Costa M. Cissampeloflavone, a chalcone-flavone dimer from Cissampelos pareira. Phytochemistry 64 (2003) 645-647
166. Ramos-Ligonio A., López-Monteon A., Talamas-Rohana P., and Rosales-Encina J.L. Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages. Parasite Immunol. 26 (2004) 409-418
167. Ribeiro T.S., Freire-de-Lima L., Previato J.O., Mendonça-Previato L., Heise N., and de Lima M.E. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi. Bioorg. Med. Chem. Lett. 14 (2004) 3555-3558
168. Rodrigues M.M., Ribeirao M., and Boscardin S.B. CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism. Immunol. Lett. 73 (2000) 43-50
169. Rodriques Coura J., and de Castro S.L. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 97 (2002) 3-24
170. Romanha A.J., Alves R.O., Murta S.M., Silva J.S., Ropert C., and Gazzinelli R.T. Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure. J. Infect. Dis. 186 (2002) 823-828
171. Ropert C., and Gazzinelli R.T. Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi. J. Endotoxin Res. 10 (2004) 425-430
172. Ropert C., Almeida I.C., Closel M., Travassos L.R., Ferguson M.A., Cohen P., and Gazzinelli R.T. Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J. Immunol. 166 (2001) 3423-3431
173. Rosestolato C.T., Dutra J.M., De Souza W., and de Carvalho T.M. Participation of host cell actin filaments during interaction of trypomastigote forms of Trypanosoma cruzi with host cells. Cell Struct. Funct. 27 (2002) 91-98
174. Rottenberg M.E., Castaños-Vélez E., de Mesquita R., Laguardia O.G., Biberfeld P., and Orn A. Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction. Eur. J. Immunol. 26 (1996) 3203-3213
175. Ruiz-Mesía L., Ruiz-Mesia W., Reina M., Martínez-Díaz R., de I.C., Guadaño A., and González-Coloma A. Bioactive Cinchona alkaloids from Remijia peruviana. J. Agric. Food Chem. 53 (2005) 1921-1926
176. Saeidnia S., Gohari A.R., Uchiyama N., Ito M., Honda G., and Kiuchi F. Two new monoterpene glycosides and trypanocidal terpenoids from Dracocephalum kotschyi. Chem. Pharm. Bull. (Tokyo) 52 (2004) 1249-1250
177. Schinor E.C., Salvador M.J., Ito I.Y., de Albuquerque S., and Dias D.A. Trypanocidal and antimicrobial activities of Moquinia kingii. Phytomedicine 11 (2004) 224-229
178. Schmidt T.J., Brun R., Willuhn G., and Khalid S.A. Anti-trypanosomal activity of helenalin and some structurally related sesquiterpene lactones. Planta Med. 68 (2002) 750-751
179. Senkovich O., Pal B., Schormann N., and Chattopadhyay D. Trypanosoma cruzi genome encodes a pteridine reductase 2 protein. Mol. Biochem. Parasitol. 127 (2003) 89-92
180. Sepúlveda-Boza S., and Cassels B.K. Plant metabolites active against Trypanosoma cruzi. Planta Med. 62 (1996) 98-105
181. Shinomiya S., Naraba H., Ueno A., Utsunomiya I., Maruyama T., Ohuchida S., Ushikubi F., Yuki K., Narumiya S., Sugimoto Y., Ichikawa A., and Oh-ishi S. Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem. Pharmacol. 61 (2001) 1153-1160
182. Sipos E.P., Witham T.F., Ratan R., Burger P.C., Baraban J., Li K.W., Piantadosi S., and Brem H. L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model. Neurosurgery 48 (2001) 392-400
183. Spector T., Berens R.L., and Marr J.J. Adenylosuccinate synthetase and adenylosuccinate lyase from Trypanosoma cruzi, Specificity studies with potential chemotherapeutic agents. Biochem. Pharmacol. 31 (1982) 225-229
184. Steenkamp D.J. Trypanosomal antioxidants and emerging aspects of redox regulation in the trypanosomatids. Antioxid. Redox Signal. 4 (2002) 105-121
185. Stoppani A.O., and de Boiso J.F. Oxidative phosphorylation in Trypanosoma cruzi. Experientia 29 (1973) 1494-1496
186. Szajnman S.H., Montalvetti A., Wang Y., Docampo R., and Rodríguez J.B. Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase. Bioorg. Med. Chem. Lett. 13 (2003) 3231-3235
187. Tarus P.K., Machocho A.K., Lang'at-Thoruwa C.C., and Chhabra S.C. Flavonoids from Tephrosia aequilata. Phytochemistry 60 (2002) 375-379
188. Temperton N.J., Wilkinson S.R., Meyer D.J., and Kelly J.M. Overexpression of superoxide dismutase in Trypanosoma cruzi results in increased sensitivity to the trypanocidal agents gentian violet and benznidazole. Mol. Biochem. Parasitol. 96 (1998) 167-176
189. Thomson L., Denicola A., and Radi R. The trypanothione-thiol system in Trypanosoma cruzi as a key antioxidant mechanism against peroxynitrite-mediated cytotoxicity. Arch. Biochem. Biophys. 412 (2003) 55-64
190. Turrens J.F. Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa. Mol. Aspects Med. 25 (2004) 211-220
191. Turrens J.F., Watts Jr. B.P., Zhong L., and Docampo R. Inhibition of Trypanosoma cruzi and T. brucei NADH fumarate reductase by benznidazole and anthelmintic imidazole derivatives. Mol. Biochem. Parasitol. 82 (1996) 125-129
192. Uchiyama N., Matsunaga K., Kiuchi F., Honda G., Tsubouchi A., Nakajima-Shimada J., and Aoki T. Trypanocidal terpenoids from Laurus nobilis L. Chem. Pharm. Bull. (Tokyo) 50 (2002) 1514-1516
193. Uchiyama N., Kiuchi F., Ito M., Honda G., Takeda Y., Khodzhimatov O.K., and Ashurmetov O.A. New icetexane and 20 norabietane diterpenes with trypanocidal activity from Dracocephalum komarovi. J. Nat. Prod. 66 (2003) 128-131
194. Une C., Andersson J., and Orn A. Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with Trypanosoma cruzi. Clin. Exp. Immunol. 134 (2003) 195-201
195. Urbina J.A., Payares G., Sanoja C., Lira R., and Romanha A.J. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. Int. J. Antimicrob. Agents 21 (2003) 27-38
196. Urbina J.A., Concepción J.L., Caldera A., Payares G., Sanoja C., Otomo T., and Hiyoshi H. In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi. Antimicrob. Agents Chemother. 48 (2004) 2379-2387
197. Valko M., Morris H., and Cronin M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 12 (2005) 1161-1208
198. Vanhoefer U., Cao S., Minderman H., Toth K., Skenderis B.S., Slovak M.L., and Rustum Y.M. d,l-Buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Clin. Cancer Res. 2 (1996) 1961-1968
199. Viarengo A., Burlando B., Ceratto N., and Panfoli I. Antioxidant role of metallothioneins: a comparative overview. Cell. Mol. Biol. (Noisy-le-grand) 46 (2000) 407-417
200. Vieira M., Dutra J.M., Carvalho T.M., Cunha-e-Silva N.L., Souto-Padron T., and Souza W. Cellular signaling during the macrophage invasion by Trypanosoma cruzi. Histochem. Cell Biol. 118 (2002) 491-500
201. Waghabi M.C., Keramidas M., Feige J.J., Araujo-Jorge T.C., and Bailly S. Activation of transforming growth factor beta by Trypanosoma cruzi. Cell. Microbiol. 7 (2005) 511-517
202. Watanabe T., Sagisaka H., Arakawa S., Shibaya Y., Watanabe M., Igarashi I., Tanaka K., Totsuka S., Takasaki W., and Manabe S. A novel model of continuous depletion of glutathione in mice treated with l-buthionine (S,R)-sulfoximine. J. Toxicol. Sci. 28 (2003) 455-469
203. Wilkinson S.R., and Kelly J.M. The role of glutathione peroxidases in trypanosomatids. Biol. Chem. 384 (2003) 517-525
204. Wilkinson S.R., Temperton N.J., Mondragon A., and Kelly J.M. Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi. J. Biol. Chem. 275 (2000) 8220-8225
205. Wilkinson S.R., Obado S.O., Mauricio I.L., and Kelly J.M. Trypanosoma cruzi expresses a plant-like ascorbate-dependent hemoperoxidase localized to the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13453-13458
206. Woolsey A.M., Sunwoo L., Petersen C.A., Brachmann S.M., Cantley L.C., and Burleigh B.A. Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation. J. Cell. Sci. 116 (2003) 3611-3622
207. World Health Organization. Control of Chagas disease: second report of the WHO expert committee. Technical Report Series vol. 905 (2002), WHO, Geneva
208. Zahoor A., Lafleur M.V., Knight R.C., Loman H., and Edwards D.I. DNA damage induced by reduced nitroimidazole drugs. Biochem. Pharmacol. 36 (1987) 3299-3304
209. Zuccotto F., Brun R., González P.D., Ruiz Pérez L.M., and Gilbert I.H. The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase. Bioorg. Med. Chem. Lett. 9 (1999) 1463-1468